Clin2
NCT06382272Possibly a fitRecruiting

Bionic breast project to reduce chronic pain after mastectomy

MastectomyBreastChronic Pain

Part of Pain clinical trials.

This study tests a new device (a neuroprosthesis) placed during breast reconstruction to see if it can reduce long-term pain after a mastectomy. If you are having both breasts removed and plan to get tissue expander reconstruction, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
8 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are scheduled to have both breasts removed (bilateral mastectomy) with tissue expander reconstruction at the University of Chicago Medicine.
  • You are having the mastectomy either to reduce your risk of breast cancer or for a small breast cancer (T1 or T2) that has not spread to lymph nodes.
  • You agree to have the tissue expander removed within 12 to 20 weeks after it is placed.
  • You have a cell phone and are willing to receive text messages from the study team.
  • You can speak and understand English or Spanish.
  • You are not currently receiving chemotherapy, and have not had prior mastectomy, chest radiation, or certain other medical conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07032753Not yet recruiting
Bionic arm interface study for above-elbow amputees

This study tests a new way to connect a bionic arm to your body, possibly improving control and feeling. It may help you use a prosthetic arm more naturally.

Chicago, Illinois
NCT07218432Recruiting
TheraBionic device study for hormone-positive breast cancer

This trial tests a device called TheraBionic P1, which uses low-level radiofrequency energy, for women with early-stage hormone receptor-positive, HER2-negative breast cancer. It is given before surgery to see if it can help shrink the tumor.

Clarkston, Michigan
NCT07672431Not yet recruiting
Medical device therapy for advanced triple-negative breast cancer

This study tests a device called TheraBionic P1 that sends a very low level of electromagnetic energy through your body. It is for people with triple-negative breast cancer that has continued to grow despite at least two earlier treatments. The goal is to see if this gentle, non-invasive approach can help.

Detroit, Michigan
NCT07146009Not yet recruiting
Nerve surgery to prevent pain after breast implant exchange

This trial tests whether a targeted nerve surgery can prevent chronic pain after mastectomy for women who are getting a second-stage implant exchange as part of breast reconstruction. If you qualify, you might receive this nerve surgery or a standard procedure, and the study will track whether you develop pain.

NCT07227831Recruiting
TheraBionic device for advanced hormone-positive breast cancer

This trial tests a device called TheraBionic P1, which uses low-level radiofrequency energy to treat advanced breast cancer that has stopped responding to standard treatments. It may offer a new option for people who have exhausted other therapies.

Bay City, Michigan
NCT07236359Not yet recruiting
Robotic nipple-sparing mastectomy with implant reconstruction

This study looks at how women feel after having a robotic nipple-sparing mastectomy with immediate implant reconstruction. It focuses on their well-being and satisfaction after surgery.

Hear when a new Mastectomy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.